Hoyle Cohen, LLC Gilead Sciences, Inc. Transaction History

Hoyle Cohen, LLC

$1.31 Billion
Q2 2024

A detailed history of Hoyle Cohen, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hoyle Cohen, LLC holds 20,300 shares of GILD stock, worth $1.88 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

20,300

Previous 20,905 2.89%

Holding current value

$1.88 Million

Previous $1.53 Million 9.08%

% of portfolio

0.11%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$63.15 - $72.88 $38,205 - $44,092	-605 Reduced 2.89%	20,300 $1.39 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $137,791 - $168,033	-1,925 Reduced 8.43%	20,905 $1.53 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $23,959 - $27,170	327 Added 1.45%	22,830 $1.85 Million
Q3 2023 Nov 02, 2023	SELL	$73.94 - $80.67 $5,175 - $5,646	-70 Reduced 0.31%	22,503 $1.69 Million
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $1,900 - $2,167	25 Added 0.11%	22,573 $1.74 Million
Q1 2023 May 05, 2023	SELL	$77.31 - $88.08 $32,624 - $37,169	-422 Reduced 1.84%	22,548 $1.87 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $74,036 - $106,290	-1,188 Reduced 4.92%	22,970 $1.97 Million
Q3 2022 Nov 02, 2022	SELL	$59.54 - $68.01 $1.72 Million - $1.96 Million	-28,843 Reduced 54.42%	24,158 $1.49 Million
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $134,199 - $151,148	-2,325 Reduced 4.2%	53,001 $3.28 Million
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $480,967 - $602,704	-8,304 Reduced 13.05%	55,326 $3.29 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $256,146 - $290,730	-3,948 Reduced 5.84%	63,630 $4.62 Million
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $307,786 - $332,067	-4,547 Reduced 6.3%	67,578 $4.72 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $87,144 - $95,217	-1,373 Reduced 1.87%	72,125 $4.97 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $12,720 - $14,513	-212 Reduced 0.29%	73,498 $4.75 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $82,425 - $93,920	-1,455 Reduced 1.94%	73,710 $4.29 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $119,294 - $149,991	-1,921 Reduced 2.49%	75,165 $4.75 Million
Q2 2020 Jul 29, 2020	SELL	$72.34 - $84.0 $118,131 - $137,172	-1,633 Reduced 2.07%	77,086 $5.93 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $100,583 - $128,833	-1,606 Reduced 2.0%	78,719 $5.89 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $199,956 - $219,946	-3,245 Reduced 3.88%	80,325 $5.22 Million
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $24,691 - $27,255	-395 Reduced 0.47%	83,570 $5.3 Million
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $21,654 - $24,283	350 Added 0.42%	83,965 $5.67 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $105,363 - $118,034	-1,685 Reduced 1.98%	83,615 $5.44 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $129,676 - $169,218	-2,142 Reduced 2.45%	85,300 $5.34 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $62,512 - $69,212	877 Added 1.01%	87,442 $6.75 Million
Q2 2018 Aug 06, 2018	SELL	$64.88 - $75.68 $74,092 - $86,426	-1,142 Reduced 1.3%	86,565 $6.13 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $82,527 - $100,610	1,133 Added 1.31%	87,707 $6.61 Million
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $6.16 Million - $7.23 Million	86,574	86,574 $6.2 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoyle Cohen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hoyle Cohen, LLC with notifications on news.

Account